Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

Investments in San Diego County startups decreased by 35% in the second quarter compared to a year ago, marking it the third ...

The 79th Indian Independence Day was celebrated with patriotic zeal and grandeur across various districts of Nagaland on ...

The firm will pick two lead agents targeting PSMA and CLDN18.2 later this year and a third STEAP1-targeting drug next year.

Wall Street traders sent stocks down from all-time highs as data showed mixed indications on how American consumers are ...

Since President Donald J. Trump took office, his unwavering commitment to revitalizing American industry has spurred trillions of dollars of ...

Newly-appointed President and CEO, Eric Risser, outlines strategic priorities for 2025 and 2026 Received $70 million upfront cash payment from Sagard Healthcare Partners under a royalty purchase agree ...